Mace Rothenberg is of Tango Therapeutics, Inc.. Currently has a direct ownership of 31,250 shares of TNGX, which is worth approximately $127,500. The most recent transaction as insider was on Nov 18, 2024, when has been sold 10,000 shares (Common Stock) at a price of $3.78 per share, resulting in proceeds of $37,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K
177.78% 3M change
525.0% 12M change
Total Value Held $127,500

Mace Rothenberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
BUY
Open market or private purchase
$37,800 $3.78 p/Share
10,000 Added 24.24%
31,250 Common Stock
Nov 14 2024
BUY
Open market or private purchase
$36,200 $3.62 p/Share
10,000 Added 32.0%
21,250 Common Stock
Jun 05 2024
BUY
Grant, award, or other acquisition
-
6,250 Added 35.71%
11,250 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
5,000 Added 50.0%
5,000 Common Stock

Also insider at

SRZN
Surrozen, Inc. Healthcare
MR

Mace Rothenberg

South San Francisco, CA

Track Institutional and Insider Activities on TNGX

Follow Tango Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNGX shares.

Notify only if

Insider Trading

Get notified when an Tango Therapeutics, Inc. insider buys or sells TNGX shares.

Notify only if

News

Receive news related to Tango Therapeutics, Inc.

Track Activities on TNGX